Status:
TERMINATED
Reactive vs. Proactive Pain Control in IBD
Lead Sponsor:
Cedars-Sinai Medical Center
Conditions:
Inflammatory Bowel Diseases
Pain
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The investigators will compare two physician behaviors for managing pain in patients with IBD: proactive vs. reactive. Both the proactive and reactive behavior/strategies are standard of care at the i...
Detailed Description
Prospective, investigator-blinded, single-institution randomized-control trial . Consecutive adult patients with IBD (Crohn's disease or ulcerative colitis) admitted to the hospital will be screened f...
Eligibility Criteria
Inclusion
- Adults with confirmed IBD diagnosis
- Admitted for primary IBD-related sign or symptom
Exclusion
- Admitted for primary non-IBD complaint
- Surgery in the last 30 days
- Alternative (non-IBD) GI diagnosis determined
- Age \<18
- Pregnancy
Key Trial Info
Start Date :
January 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2022
Estimated Enrollment :
33 Patients enrolled
Trial Details
Trial ID
NCT03798405
Start Date
January 1 2019
End Date
July 1 2022
Last Update
July 22 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cedars-Sinai Medical Center
Los Angeles, California, United States, 90048